Thrombocytopenia: A Marker Of Maternal And Fetal Outcome In Pregnancy Induced Hypertension

Dr C P Jishabai; Dr Sameera A

Volume : V, Issue : X, October - 2016

Thrombocytopenia: A Marker Of Maternal And Fetal Outcome In Pregnancy Induced Hypertension

Dr C P Jishabai, Dr Sameera A

Abstract :

Background and objective: Pregnancy Induced Hypertension (PIH) is the commonest medical disorder occurring in pregnancy, leading to poor maternal and fetal outcome. (1) Thrombocytopenia (low platelet count) is the most common haematological abnormalitiy seen in these women. (2,3) This study aims to find out the degree of thrombocytopenia in women with PIH and its relationship with the maternal and fetal outcome. Materials and methods: This study was conducted in the department of Obstetrics and Gynecology, Government Medical College, Kozhikode for a period of one year from December 2013. 302 women with PIH were selected and their platelet count was measured serially. They were divided into two groups with Group A having platelet count less than or equal to 1,50000/mm3 and Group B, more than 1,50000/ mm3. Maternal and fetal outcome were compared among the groups. Results: Mean platelet count in severe preeclampsia was 1,42000/mm3 and in eclampsia was 1,34000/mm3. Maternal complications like severe preeclampsia, eclampsia, HELLP syndrome, placental auption, renal failure and post partum hemorrhage were more among Group A. Poor perinatal outcome was also observed in Group A with low birth weight, intra–uterine growth retardation (IUGR) and intra–uterine death (IUD).It is concluded that thrombocytopenia is associated with poor maternal and fetal outcome in patients with pregnancy induced hypertension